Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium.
Mol Syst Biol. 2010 Jul;6:392. doi: 10.1038/msb.2010.46.
Obesity is characterised by altered gut microbiota, low-grade inflammation and increased endocannabinoid (eCB) system tone; however, a clear connection between gut microbiota and eCB signalling has yet to be confirmed. Here, we report that gut microbiota modulate the intestinal eCB system tone, which in turn regulates gut permeability and plasma lipopolysaccharide (LPS) levels. The impact of the increased plasma LPS levels and eCB system tone found in obesity on adipose tissue metabolism (e.g. differentiation and lipogenesis) remains unknown. By interfering with the eCB system using CB(1) agonist and antagonist in lean and obese mouse models, we found that the eCB system controls gut permeability and adipogenesis. We also show that LPS acts as a master switch to control adipose tissue metabolism both in vivo and ex vivo by blocking cannabinoid-driven adipogenesis. These data indicate that gut microbiota determine adipose tissue physiology through LPS-eCB system regulatory loops and may have critical functions in adipose tissue plasticity during obesity.
肥胖的特征是肠道微生物群改变、低度炎症和内源性大麻素(eCB)系统张力增加;然而,肠道微生物群和 eCB 信号之间的明确联系尚未得到证实。在这里,我们报告肠道微生物群调节肠道 eCB 系统张力,这反过来又调节肠道通透性和血浆脂多糖(LPS)水平。肥胖症中发现的增加的血浆 LPS 水平和 eCB 系统张力对脂肪组织代谢(例如分化和脂肪生成)的影响尚不清楚。通过在瘦鼠和肥胖鼠模型中使用 CB1 激动剂和拮抗剂干扰 eCB 系统,我们发现 eCB 系统控制肠道通透性和脂肪生成。我们还表明,LPS 通过阻断大麻素驱动的脂肪生成,作为体内和体外控制脂肪组织代谢的主开关。这些数据表明,肠道微生物群通过 LPS-eCB 系统调节环来决定脂肪组织生理学,并且在肥胖期间脂肪组织可塑性中可能具有关键功能。